Thalidomide Capsule

Thalidomide functions as a potent immunomodulatory agent that leverages anti-angiogenic and anti-inflammatory properties to exert synergistic anti-neoplastic effects, particularly when integrated into multi-drug regimens for plasma cell dyscrasias. By modulating cytokine production and disrupting the tumor microenvironment, this therapy provides a targeted clinical benefit in suppressing malignant cell proliferation and improving patient outcomes in complex hematologic conditions. The capsule delivery system ensures precise oral administration and reliable gastrointestinal absorption, maintaining consistent therapeutic plasma concentrations while enhancing patient compliance during extended treatment cycles.